Back to top of page

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)

List of required information for application:

1. Name of the investigator or research team

2. Contact information (email, phone number, address)

3. Title of the proposed clinical trial

4. Brief summary or abstract of the clinical trial

5. Phase of the clinical trial (e.g., Phase I, Phase II, Phase III)

6. Hypothesis or research question being addressed by the clinical trial

7. Description of how the clinical trial aligns with the research mission of the participating IC

8. Proposed project period (6 or 7 years)

9. Planned timeline for the clinical trial, including milestones and deliverables

10. Budget estimate for the entire project period

11. Description of the study population and recruitment strategies

12. Detailed study protocol, including study design, interventions, and outcome measures

13. Qualifications and experience of the investigator or research team

14. Any preliminary data or previous research related to the proposed clinical trial

15. Potential risks and benefits of participating in the clinical trial

16. Plans for data management, analysis, and dissemination of results

17. Regulatory considerations and plans for obtaining necessary approvals (e.g., IRB approval)

18. Plan for monitoring and ensuring participant safety during the clinical trial

19. Any collaborations or partnerships relevant to the clinical trial

20. Letters of support or endorsement from collaborators, mentors, or other relevant individuals or organizations.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows